Program Schedule

2017 Schedule 

Designed to blend the latest advancements in science with practical clinical approaches to patient management, PCNA’s Annual Cardiovascular Nursing Symposium features keynote addresses, lectures and workshops presented by world-renowned authorities in cardiovascular risk reduction and disease management.

Thursday, April 6           Pharmacology Preconference

Pharmacology Preconference may be attended as a stand-alone event.


11:15 - 12:15 PM   Lunch and Commercial Event
Rethinking Statin Selection: Leveraging the Patient-Centric Approach
Hosted by Kowa Pharmaceuticals, Inc.
12:30 - 12:35 PM        Welcome and Course Overview
Course Director, Cindy Lamendola, MSN, NP, FAHA, FPCNA
12:35 - 1:30 PM   Cardio-Metabolic Risk Reduction in patients with pre-diabetes and DM2
Cindy Lamendola, MSN, NP, FAHA, FPCNA
1:30 - 1:45 PM
"Ask the Expert" case discussion
1:45 - 2:05 PM

2:05 - 3:05 PM   It’s a Balancing Act: Medication Management in Patients with CKD and CVD
Carol Headley DNSc. ACNP, RN, CNN
3:05 - 3:20 PM    "Ask the Expert" case discussion
3:20 - 3:40 PM    Break 
3:40 - 4:40 PM   Pharmacological Management of the Cardiac Patient with Depression and/or Anxiety
Wei Jiang MD
4:40 - 4:50 PM   "Ask the Expert" case discussion
4:50 - 5:30 PM   Complex Cases and Panel Discussion
5:30 - 6:30 PM    Dinner and Commercial Event
Putting Guidelines into Practice: New Recommendations for Optimal Treatment of Heart Failure with Reduced Ejection Fraction (HFREF)
Hosted by Novartis Pharmaceuticals Corporation

Friday, April 7       Annual Symposium General Sessions

Exhibit Hours are 12:30 - 2:15 PM and 5:30 to 7:00 PM

7:30 - 8:30 AM   Breakfast and Commercial Event
Working Together: Coordination of Care in Heart Failure, Hosted by Novartis Pharmaceuticals Corporation
8:30 - 8:45 AM   President's Welcome 
8:45 - 9:35 AM   A Call to Action: Population Health and CVD Prevention
John Rumsfeld, MD PhD
9:35 - 9:50 AM   Break 
9:50 - 10:40 AM   CVD Risk Assessment and Health in Women Across the Lifespan 
Judith Regensteiner, PhD
10:40 AM - 11:30 AM
Obesity and Health Behaviors: Success Stories from the National Weight Control Registry 
James O. Hill, PhD
11:30 - 12:00 PM   Panel Discussion with Judith Regensteiner, PhD and James O. Hill, PhD
12:00 - 1:00 PM   Lunch and Commercial Event
Clinical Evaluation of Pure EPA
Hosted by Amarin Pharma, Inc.
 12:00 - 1:00 PM   Leadership Luncheon (invite only) 
12:30 - 2:15 PM
  Exhibit Hall Open
2:15 - 3:15 PM   Pharmacological and Surgical Management for Weight Loss
John Morton, MD, MPH
3:15 - 3:30 PM    Break 
3:30 - 5:30 PM   Skill Building Sessions (pick one)

Effective Strategies for Engaging Patients in Health Behavior Change
Lola Coke PhD, RN, ACNS-BC and Nancy Houston Miller BSN, RN

Chest pain! How to Perform a Comprehensive Evaluation for Ischemia. 
Joan Mersch MSN, RN

Moderated Poster Session
 5:30 - 7:00 PM   Opening Reception
Hosted by the Journal of Cardiovascular Nursing and Novartis Pharmaceuticals Corporation
 7:00 - 8:00 PM   Dinner and Commercial Event
Thombosis: AFib & DVT/PE, An Exploration in Risk Reduction
Hosted by Janssen Pharmaceuticals, Inc.

Saturday, April 8

Exhibit hours are 10:45 - 11:30 AM

7:30 - 8:30 AM   Breakfast Program (CE): LDL Cholesterol Lowering in the Management of
Atherosclerotic Cardiovascular Disease Risk: Emerging Insights
Supported by an educational grant from Amgen, Inc.
Lynne Braun, PhD, CNP, CLS
Michael Miller, MD
8:30 - 8:45 AM   Welcome and Announcement of Poster Winners
8:45 - 9:45 AM   Heart Failure: Evidence-Based Strategies to Improve Patient Outcomes
Supported by an educational grant from Novartis Pharmaceuticals Corporation
Kim Newlin, MS, ANP
9:45 - 10:45 AM    Million Hearts in 2017: The 5-Year Challenge to Prevent Heart Attack and Stroke
Janet Wright, MD, FACC
10:45 - 11:30 AM   Exhibits Hall Open and Morning Break
11:30 - 12:30 PM    Physical Activity: The Magic Bullet
William Haskell PhD
12:30 - 1:30 PM   Lunch and Product Theater
Repatha®(Evolocumab):A Focused Clinical Review
Hosted by Amgen, Inc.
1:30 - 2:00 PM    Winning Abstract Presentations - Main Arena
2:00 - 2:45 PM   Making the Head Heart and Vascular Link: CVD Risk Factors and Dementia
Valentin Fuster MD, PhD
2:45 - 3:30 PM   Cardio-Metabolic Risk Management: Promoting Health and Preventing Disease
Robert Eckel MD
3:30 - 4:00 PM   Lifestyle Panel Discussion with William Haskell, PhD and Robert Eckel MD
4:00 - 4:15 PM   Afternoon Break
4:15 - 5:15 PM    Breakout Sessions: Choose one
    Interpreting and Translating Research into Practice
Cheryl R. Dennison Himmelfarb,RN, ANP, PhD, FAHA, FPCNA, FAAN

Structural Heart Interventions: Valves, Clips and Plugs, Oh, My!
Michael Kim, MD

Health Effects of Marijuana, E-cigarettes and Vaping
Marian Piano, PhD, RN
5:30 - 6:30 PM    Dinner Event
PCSK9 Inhibitor Access Barriers - Issues and Recommendations
Hosted by the American Society for Preventive Cardiology
6:30 PM and on   Chapter Meet-ups

Sunday, April 9

7:45 - 8:45 AM   Breakfast Program: A Team-Based Approach for Effective VTE Treatment
James Williams, MD
G. Clinton Shedd, DNP, FNP-BC, RN
Randy Fenninger
8:45 - 9:15 AM  

PCNA Member Celebration and Awards Ceremony

9:15 - 10:15 AM   Healthy Aging: Improving Quality of Life in Older Adults with Diabetes and Chronic Disease
A Joint Session of the AHA CV Nursing Council and PCNA
Deborah Chyun PhD, RN
10:15 - 10:30 AM    Break

10:30 - 11:30 AM


Prevention and Management of Stroke Across the Continuum of Care
Sarah Livesay DNP, RN, ACNP-BC, ACNS-BC

11:30 AM - 12:15 PM


Technology and Cardiovascular Health: Harvesting the Power of Innovation 
Michael V. McConnell, MD, MSEE
12:15 - 12:30 PM   Closing Remarks and Prize Drawing

Accreditation Statement

This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). Multiple educational grants have been requested to support this program. PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602. This program was planned in accordance with AANP CE Policies and Commercial Support Standards.